Fox Business - The Power to Prosper
Search Site

McKesson

2Q earnings scorecard

S&P Capital IQ Chief Equity Strategist Sam Stovall and OppenheimerFunds CIO Krishna Memani on recent earnings report and where investors can find bargains.

Read More

  1. McKesson Holder's Dont Back Celesio Deal

    McKesson (NYSE:MCK) said Monday it didn't receive the required shareholder support in its attempt to purchase German drug and pharmacy giant Celesio, less than a wee...

  2. McKesson Says Celesio Deal Falls Through

    Drug distribution giant McKesson Corp. said Monday that its plans to acquire Celesio AG [s:de:cls1] have fallen through as it was unable to get the 75% necessary vot...

  3. Investors Stick With Health Care Stocks

    Investors tend to stick with what works.  Perhaps that explains why they continue to flock to health care stocks.  The sector was second-best performer in 2013, rall...

  4. McKesson Sweetens Buyout Bid for Celesio

    U.S. drug distributor McKesson (NYSE:MCK) unveiled a deal on Thursday with Celesio's majority shareholder to sweeten its buyout offer for the German company.The deal...

  5. CVS, Cardinal Health Forge Generic Drug Deal

    Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcin...

  6. McKesson Up 5% On Reported Talks With Celesio

    Shares of McKesson Corp. jumped 5% on Tuesday, the biggest gainer on the S&P 500 . The stock move came after The Wall Street Journal reported that McKesson is in adv...

  7. WSJ: McKesson Nears $5.08B Buyout of Celesio

    Drug distributor McKesson (NYSE:MCK) is reportedly in advanced talks to acquire German rival Celesio for more than $5 billion, in a move aimed at giving the U.S. com...

  8. Symantec CFO Leaves For McKesson

    Symantec Corp. said Monday afternoon that chief financial officer James Beer is leaving the company to take the CFO spot at McKesson Corp. . Beer has been CFO of Sym...

  9. McKesson Beats On Earnings, Falls Short On Revenue

    McKesson Corp. on Thursday said first-quarter net income was $424 million, or $1.83 a share, compared with $380 million, or $1.58 a share, reported a year ago. Sales...

  10. ISS urges vote against four McKesson directors over CEO pay

    Proxy advisory firm Institutional Shareholder Services (ISS) is urging shareholders of McKesson Corp to vote against the re-election of four directors, citing the fi...

  11. Proxy adviser ISS urges vote against four McKesson directors: WSJ

    Proxy advisory firm Institutional Shareholder Services is urging shareholders of McKesson Corp to vote against the re-election of four directors, citing the firm's p...

  12. Celesio fires CEO Pinger after management dispute

    The supervisory board of Celesio has sacked the German drugs distributor's chief executive, Markus Pinger, with immediate effect after a falling out with the head of...

  1. Oracle’s $10B bond

    FBN’s Liz MacDonald on Oracle’s $10B bond offering.

  2. The key to stock-picking perfection

    M.D. Sass CEO Martin D. Sass gives insight into the markets.

  3. Market correction coming?

    S&P Capital IQ chief equity strategist Sam Stovall and Wells Fargo Securities senior equity strategist Gina Martin Adams on whether 2014 will be a year of consolidation.

  4. Where to allocate your assets

    Morgan Stanley chief equity strategist Adam Parker on where to invest today.

  5. McKesson CEO Takes $45M Pension Pay Cut

    McKesson (NYSE:MCK) lowered the pension payment of chief executive John Hammergren by $45 million on Friday in response to increasing shareholder pressure.The compan...

  6. McKesson Earnings Drop But Sales Climb

    Drug distribution giant McKesson Corp. said Thursday that third-quarter net income was $64 million, or 28 cents a share, compared with $298 million, or $1.24 a share...

  7. Two Healthcare Stocks Hit All-Time Highs

    Today's steep stock market selloff notwithstanding, two players in the health care sector are bucking the downward trend and rallying to all-time highs.Medical devic...

‹ Prev12345Next ›
Freebase CC-BY
Source: McKesson on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL